(-)-alpha-phellandrene increases expression ISO RGD:1322910 6480464 alpha phellandrene results in increased expression of RRAS mRNA CTD PMID:25075043 1,1-dichloroethene increases expression ISO RGD:1322911 6480464 vinylidene chloride results in increased expression of RRAS mRNA CTD PMID:26682919 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of RRAS mRNA CTD PMID:30723492 17beta-estradiol decreases expression ISO RGD:1322910 6480464 Estradiol results in decreased expression of RRAS mRNA CTD PMID:16029874 17beta-estradiol multiple interactions ISO RGD:1322910 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of RRAS mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1322911 6480464 Tetrachlorodibenzodioxin affects the expression of RRAS mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of RRAS mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1322910 6480464 Tetrachlorodibenzodioxin results in increased expression of RRAS mRNA CTD PMID:20106945 , PMID:21632981 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of RRAS protein CTD PMID:34915118 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1322911 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of RRAS mRNA CTD PMID:16054899 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1322910 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RRAS mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RRAS mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide decreases expression ISO RGD:1322911 6480464 Fenretinide results in decreased expression of RRAS mRNA CTD PMID:16467112 , PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:1322910 6480464 Decitabine affects the expression of RRAS mRNA CTD PMID:23300844 5-fluorouracil affects response to substance ISO RGD:1322910 6480464 RRAS protein affects the susceptibility to Fluorouracil CTD PMID:16217747 aconitine increases expression EXP 6480464 Aconitine results in increased expression of RRAS protein CTD PMID:33236894 actinomycin D increases expression ISO RGD:1322910 6480464 Dactinomycin results in increased expression of RRAS mRNA CTD PMID:21527772 aflatoxin B1 increases expression ISO RGD:1322910 6480464 Aflatoxin B1 results in increased expression of RRAS mRNA CTD PMID:21527772 , PMID:27153756 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of RRAS mRNA CTD PMID:20488242 all-trans-retinoic acid increases expression ISO RGD:1322910 6480464 Tretinoin results in increased expression of RRAS mRNA CTD PMID:23724009 alpha-phellandrene increases expression ISO RGD:1322910 6480464 alpha phellandrene results in increased expression of RRAS mRNA CTD PMID:25075043 aristolochic acid decreases expression ISO RGD:1322910 6480464 aristolochic acid I results in decreased expression of RRAS mRNA CTD PMID:33212167 arsane increases methylation ISO RGD:1322910 6480464 Arsenic results in increased methylation of RRAS gene CTD PMID:24525453 arsenic atom increases methylation ISO RGD:1322910 6480464 Arsenic results in increased methylation of RRAS gene CTD PMID:24525453 arsenous acid increases expression ISO RGD:1322910 6480464 Arsenic Trioxide results in increased expression of RRAS mRNA CTD PMID:20458559 atrazine increases expression ISO RGD:1322910 6480464 Atrazine results in increased expression of RRAS mRNA CTD PMID:22378314 benzo[a]pyrene increases expression ISO RGD:1322910 6480464 Benzo(a)pyrene results in increased expression of RRAS mRNA CTD PMID:20106945 benzo[a]pyrene affects methylation ISO RGD:1322910 6480464 Benzo(a)pyrene affects the methylation of RRAS 3' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1322911 6480464 Benzo(a)pyrene results in increased expression of RRAS mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:1322911 6480464 Benzo(a)pyrene results in decreased expression of RRAS mRNA CTD PMID:19770486 , PMID:21715664 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of RRAS mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1322911 6480464 bisphenol A results in decreased expression of RRAS mRNA CTD PMID:33221593 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of RRAS gene CTD PMID:28505145 bisphenol A multiple interactions ISO RGD:1322910 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RRAS mRNA, [Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of RRAS protein CTD PMID:28628672 , PMID:31629898 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of RRAS mRNA CTD PMID:30816183 more ... bisphenol F multiple interactions ISO RGD:1322910 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RRAS mRNA CTD PMID:28628672 butyric acid increases expression ISO RGD:1322910 6480464 Butyric Acid results in increased expression of RRAS mRNA CTD PMID:34581912 cadmium dichloride increases methylation EXP 6480464 Cadmium Chloride results in increased methylation of RRAS promoter CTD PMID:22457795 calcitriol multiple interactions ISO RGD:1322910 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of RRAS mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:1322910 6480464 Calcitriol results in increased expression of RRAS mRNA CTD PMID:21592394 chlordecone decreases expression ISO RGD:1322911 6480464 Chlordecone results in decreased expression of RRAS mRNA CTD PMID:33711761 cisplatin increases expression ISO RGD:1322911 6480464 Cisplatin results in increased expression of RRAS mRNA CTD PMID:21151649 cisplatin affects expression ISO RGD:1322910 6480464 Cisplatin affects the expression of RRAS mRNA CTD PMID:23300844 clofibrate decreases expression ISO RGD:1322911 6480464 Clofibrate results in decreased expression of RRAS mRNA CTD PMID:17585979 clofibrate multiple interactions ISO RGD:1322911 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of RRAS mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of RRAS mRNA] CTD PMID:17585979 cobalt dichloride decreases expression ISO RGD:1322910 6480464 cobaltous chloride results in decreased expression of RRAS mRNA CTD PMID:19320972 , PMID:19376846 copper atom multiple interactions ISO RGD:1322910 6480464 [Chelating Agents binds to Copper] which results in increased expression of RRAS mRNA, [Disulfiram binds to Copper] which results in increased expression of RRAS mRNA CTD PMID:24690739 , PMID:30911355 copper(0) multiple interactions ISO RGD:1322910 6480464 [Chelating Agents binds to Copper] which results in increased expression of RRAS mRNA, [Disulfiram binds to Copper] which results in increased expression of RRAS mRNA CTD PMID:24690739 , PMID:30911355 crocidolite asbestos affects expression ISO RGD:1322910 6480464 Asbestos, Crocidolite affects the expression of RRAS mRNA CTD PMID:17331233 cyclosporin A increases expression ISO RGD:1322910 6480464 Cyclosporine results in increased expression of RRAS mRNA CTD PMID:25562108 cyproconazole increases expression ISO RGD:1322911 6480464 cyproconazole results in increased expression of RRAS mRNA CTD PMID:22334560 cytarabine decreases expression ISO RGD:1322910 6480464 Cytarabine results in decreased expression of RRAS mRNA CTD PMID:21198554 dexamethasone multiple interactions ISO RGD:1322911 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of RRAS mRNA CTD PMID:16054899 dexamethasone multiple interactions ISO RGD:1322910 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RRAS mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RRAS mRNA CTD PMID:28628672 diarsenic trioxide increases expression ISO RGD:1322910 6480464 Arsenic Trioxide results in increased expression of RRAS mRNA CTD PMID:20458559 dibutyl phthalate increases expression ISO RGD:1322911 6480464 Dibutyl Phthalate results in increased expression of RRAS mRNA CTD PMID:21266533 dioxygen increases expression ISO RGD:1322910 6480464 Oxygen deficiency results in increased expression of RRAS mRNA CTD PMID:17914565 disulfiram multiple interactions ISO RGD:1322910 6480464 [Disulfiram binds to Copper] which results in increased expression of RRAS mRNA CTD PMID:24690739 diuron increases expression EXP 6480464 Diuron results in increased expression of RRAS mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1322910 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RRAS mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:1322910 6480464 entinostat results in increased expression of RRAS mRNA CTD PMID:27188386 epoxiconazole increases expression ISO RGD:1322911 6480464 epoxiconazole results in increased expression of RRAS mRNA CTD PMID:22334560 etoposide increases expression ISO RGD:1322910 6480464 Etoposide results in increased expression of RRAS mRNA CTD PMID:21527772 ferrosoferric oxide multiple interactions ISO RGD:1322910 6480464 [Ferrosoferric Oxide binds to titanium dioxide] which results in increased expression of RRAS protein CTD PMID:30098274 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of RRAS mRNA CTD PMID:33387578 glafenine increases expression EXP 6480464 Glafenine results in increased expression of RRAS mRNA CTD PMID:24136188 glyphosate increases expression ISO RGD:1322910 6480464 glyphosate results in increased expression of RRAS mRNA CTD PMID:31295307 hydroxyurea increases expression ISO RGD:1322911 6480464 Hydroxyurea results in increased expression of RRAS mRNA CTD PMID:12929121 indometacin multiple interactions ISO RGD:1322910 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RRAS mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RRAS mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:1322910 6480464 Ivermectin results in decreased expression of RRAS protein CTD PMID:32959892 lipopolysaccharide decreases expression ISO RGD:1322911 6480464 Lipopolysaccharides results in decreased expression of RRAS mRNA CTD PMID:12057914 lipopolysaccharide increases expression ISO RGD:1322911 6480464 Lipopolysaccharides results in increased expression of RRAS mRNA CTD PMID:27339419 mercury dibromide decreases expression ISO RGD:1322910 6480464 mercuric bromide results in decreased expression of RRAS mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1322910 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RRAS mRNA CTD PMID:27188386 methotrexate increases expression ISO RGD:1322910 6480464 Methotrexate results in increased expression of RRAS mRNA CTD PMID:21678067 N-methyl-4-phenylpyridinium increases expression ISO RGD:1322910 6480464 1-Methyl-4-phenylpyridinium results in increased expression of RRAS mRNA CTD PMID:24810058 N-nitrosodiethylamine increases expression ISO RGD:1322910 6480464 Diethylnitrosamine results in increased expression of RRAS mRNA CTD PMID:21527772 p-anisidine increases expression ISO RGD:1322911 6480464 4-anisidine results in increased expression of RRAS mRNA CTD PMID:12929121 paracetamol multiple interactions ISO RGD:1322911 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of RRAS mRNA more ... CTD PMID:17585979 , PMID:29246445 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of RRAS mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1322911 6480464 Acetaminophen results in increased expression of RRAS mRNA CTD PMID:29246445 paracetamol increases expression ISO RGD:1322910 6480464 Acetaminophen results in increased expression of RRAS mRNA CTD PMID:22230336 paracetamol affects expression ISO RGD:1322911 6480464 Acetaminophen affects the expression of RRAS mRNA CTD PMID:17562736 phenobarbital multiple interactions ISO RGD:1322911 6480464 NR1I3 protein promotes the reaction [Phenobarbital results in increased expression of RRAS mRNA] CTD PMID:19482888 phenobarbital increases expression ISO RGD:1322911 6480464 Phenobarbital results in increased expression of RRAS mRNA CTD PMID:19482888 phenol red multiple interactions ISO RGD:1322910 6480464 [Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of RRAS protein CTD PMID:31629898 potassium chromate decreases expression ISO RGD:1322910 6480464 potassium chromate(VI) results in decreased expression of RRAS mRNA CTD PMID:22714537 propiconazole increases expression ISO RGD:1322911 6480464 propiconazole results in increased expression of RRAS mRNA CTD PMID:22334560 quercetin increases expression ISO RGD:1322910 6480464 Quercetin results in increased expression of RRAS mRNA CTD PMID:21632981 raloxifene affects expression ISO RGD:1322910 6480464 Raloxifene Hydrochloride affects the expression of RRAS mRNA CTD PMID:14699072 SB 431542 multiple interactions ISO RGD:1322910 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RRAS mRNA CTD PMID:27188386 sodium arsenite decreases expression ISO RGD:1322910 6480464 sodium arsenite results in decreased expression of RRAS protein CTD PMID:24431212 sodium arsenite increases expression ISO RGD:1322910 6480464 sodium arsenite results in increased expression of RRAS protein CTD PMID:24431212 sodium fluoride increases expression ISO RGD:1322911 6480464 Sodium Fluoride results in increased expression of RRAS protein CTD PMID:28918527 Soman increases expression EXP 6480464 Soman results in increased expression of RRAS mRNA CTD PMID:19281266 sunitinib decreases expression ISO RGD:1322910 6480464 Sunitinib results in decreased expression of RRAS mRNA CTD PMID:31533062 temozolomide decreases expression ISO RGD:1322910 6480464 Temozolomide results in decreased expression of RRAS mRNA CTD PMID:31758290 testosterone multiple interactions ISO RGD:1322910 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of RRAS mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1322910 6480464 Testosterone results in increased expression of RRAS mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:1322911 6480464 Carbon Tetrachloride results in increased expression of RRAS mRNA CTD PMID:31919559 thalidomide decreases expression ISO RGD:1322911 6480464 Thalidomide results in decreased expression of RRAS mRNA CTD PMID:26006729 , PMID:26217789 titanium dioxide increases expression ISO RGD:1322910 6480464 titanium dioxide results in increased expression of RRAS protein CTD PMID:30098274 titanium dioxide multiple interactions ISO RGD:1322910 6480464 [Ferrosoferric Oxide binds to titanium dioxide] which results in increased expression of RRAS protein CTD PMID:30098274 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1322910 6480464 tris(2-butoxyethyl) phosphate affects the expression of RRAS mRNA CTD PMID:29024780 valproic acid increases methylation ISO RGD:1322910 6480464 Valproic Acid results in increased methylation of RRAS gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1322910 6480464 Valproic Acid affects the expression of RRAS mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1322910 6480464 Valproic Acid results in increased expression of RRAS mRNA CTD PMID:19101580 vancomycin decreases expression ISO RGD:1322911 6480464 Vancomycin results in decreased expression of RRAS mRNA CTD PMID:18930951 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of RRAS mRNA CTD PMID:23034163 vorinostat decreases expression ISO RGD:1322910 6480464 vorinostat results in decreased expression of RRAS protein CTD PMID:20543569 XL147 multiple interactions ISO RGD:1322911 6480464 XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RRAS mRNA] CTD PMID:29891994
